Back
Cadence Bank Vs. Apellis Pharmaceuticals Industry Stock Comparison
Buy
92
CADE
Cadence Bank
Last Price:
38.92
Seasonality Move:
3.51%
Sell
47
APLS
Apellis Pharmaceuticals
Last Price:
28.96
Seasonality Move:
20.78%
Buy
92
Cadence Bank (CADE)
is a Buy
Is Cadence Bank a Buy, Sell or Hold?
- The current Cadence Bank [CADE] share price is $38.73. The Score for CADE is 92, which is 84% above its historic median score of 50, and infers lower risk than normal.
- CADE is currently trading in the 90-100% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Sell
47
Apellis Pharmaceuticals (APLS)
is a Sell
Is Apellis Pharmaceuticals a Buy, Sell or Hold?
- The current Apellis Pharmaceuticals [APLS] share price is $29.26. The Score for APLS is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
- APLS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CADE Stock Price Chart
What is Cadence Bank's stock price today?
-
The Cadence Bank share price today is $38.73
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CADE is experiencing slight selling pressure.
APLS Stock Price Chart
What is Apellis Pharmaceuticals's stock price today?
-
The Apellis Pharmaceuticals share price today is $29.26
The current trend is relatively stagnant and APLS is experiencing slight buying pressure.
CADE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.6 | Buy |
| Relative Strength Index (14 RSI): | 71.08 | Buy |
| Chaikin Money Flow: | -301646 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (31.93 - 36.41) | Buy |
| Bollinger Bands (100): | (29.28 - 33.94) | Buy |
APLS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.2 | Sell |
| Relative Strength Index (14 RSI): | 52.74 | Buy |
| Chaikin Money Flow: | 179519 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (26.95 - 28.71) | Buy |
| Bollinger Bands (100): | (29.49 - 39.35) | Sell |
CADE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 36.47 | Buy |
| 20-day SMA: | 34.7 | Buy |
| 50-day SMA: | 32.73 | Buy |
| 200-day SMA: | 29.71 | Buy |
| 8-day EMA: | 37.06 | Buy |
| 20-day EMA: | 35.18 | Buy |
| 50-day EMA: | 33.35 | Buy |
| 200-day EMA: | 30.12 | Buy |
APLS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 28.88 | Buy |
| 20-day SMA: | 28.02 | Buy |
| 50-day SMA: | 30.86 | Sell |
| 200-day SMA: | 43.85 | Sell |
| 8-day EMA: | 28.92 | Buy |
| 20-day EMA: | 28.61 | Buy |
| 50-day EMA: | 30.58 | Sell |
| 200-day EMA: | 40.41 | Sell |
Cadence Bank Earnings Growth & CADE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.34 per share, and an increase next year of $0.15 per share.
Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.75 per share, and an increase next year of $0.83 per share.
Cadence Bank Technical Analysis
| Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Apellis Pharmaceuticals Technical Analysis
| Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||